Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma
John Nemunaitis(Gradalis (United States)), Dale Ando(Sangamo BioSciences (United States)), Janet Bruce(Baylor University Medical Center), James A. Merritt(NewGen Therapeutics (United States)), Kieron J. Kowal, Dee Wynne, Wilson B. Edwards(Mallinckrodt (United States)), R. Steven Paulson(Research Institute of Dallas), Marilyn C. Pike(Bethesda Hospital), Timothy Fong, Nadine Ognoskie(Texas Oncology), Gerald M. Edelman(Research Institute of Dallas), Joan M. Robbins
Cited by 40
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|719
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
|Circulation|2002|652
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer
|Science Translational Medicine|2015|438